Is LENZ Therapeutics, Inc. (LENZ) a Buy, Sell, or Hold?
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$4.81 USD
-$0.12 (-2.43%)
- Volume
- 437.04K
- Average Volume
- 836.63K
- Market Capitalization
- $150.81M
- P/E Ratio
- -1.34
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $50.40
- Year Low
- $4.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.40
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Evert Schimmelpennink |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | LENZ |
| CUSIP | 52635N103 |
| CIK | 0001815776 |
| Web | https://www.lenz-tx.com |
| Phone | (858) 925-7000 |
| Currency | USD |
| Employees | 152 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 10.40 |
| Quick Ratio | 10.26 |
| Cash Ratio | 0.96 |
Sales & Book Value
| Annual Sales | $19.09M |
| Price / Sales | 7.19 |
| Cash Flow | -2.79 |
| Price / Cash Flow | -1.72 |
| Price / Book | 0.61 |
Price Target and Rating
| Average Stock Price Forecast | $12.00 |
| High Stock Price Forecast | $12.00 |
| Low Stock Price Forecast | $12.00 |
| Forecast Upside/Downside | -59.92% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 5 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-2.85 |
| Trailing P/E Ratio | -1.34 |
| PEG Ratio | 0.02 |
| P/E Growth | 0.02 |
| Net Income | $-82.13M |
| Net Margin | -519.30% |
| Pretax Margin | -516.91% |
| Return on Equity | -46.82% |
| Return on Assets | -39.99% |
Financials Score
| AltmanZ Score | 2.25 |
| Piotroski Score | 3.00 |
| Working Capital | 242.56M |
| Total Assets | 272.54M |
| Ebit | -108.49M |
| Market Cap | 165.08M |
| Total Liabilities | 26.04M |
Poll Results
About LENZ Therapeutics, Inc. (NASDAQ:LENZ) Stock
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California. ...
2026-07-06 08:15:00
VIZZ is now available for those who qualify through a convenient telehealth platform in addition to existing access through eye care professionals
2026-06-24 08:30:00
SAN DIEGO and MELBOURNE, Australia, June 24, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Arrotex Pharmaceuticals Pty Ltd. (“Arrotex”) today announced an exclusive license and commercialization agreement for Arrotex to register and commercialize VIZZ™ for the treatment of presbyopia in Australia and New Zealand.
LENZ Therapeutics adds China partner for presbyopia drug VIZZ
2026-06-08 11:35:09
LENZ Therapeutics, Inc. (NASDAQ:LENZ) said Everest Medicines has acquired the rights to develop and commercialize VIZZ, also known as LNZ100, in Greater China. Under the agreement, Everest Medicines (HKEX:1952) takes on development and commercialization of the drug in the Greater China market, LENZ said.
2026-06-07 19:30:00
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027
LENZ Therapeutics to Participate in Upcoming Investor Conferences
2026-05-26 08:00:00
SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults, today announced that company management will participate in the following upcoming investor conferences:
2026-05-12 07:54:21
Pre-Market Stock Futures: The futures are trading lower on Tuesday, but another week and another set of new highs for the S&P 500 and the Nasdaq, as AI fever overshadowed Iran's peace counteroffer dismissal on Monday. The stock market opened lower on the rejection of President Trump's peace offering, but buyers once again circled the... Here Are Tuesday's Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe's, Matador Resources, Toast and More
LENZ Therapeutics, Inc. (LENZ) Q1 2026 Earnings Call Transcript
2026-05-11 21:40:42
LENZ Therapeutics, Inc. (LENZ) Q1 2026 Earnings Call Transcript
LENZ Therapeutics Q1 Earnings Call Highlights
2026-05-11 21:08:02
LENZ Therapeutics NASDAQ: LENZ reported first-quarter 2026 results that showed continued prescription growth for its presbyopia eye drop VIZZ, while management acknowledged that new patient adoption and routine prescribing by eye care professionals are developing more gradually than expected.
Frequently Asked Questions
-
What is the current LENZ Therapeutics, Inc. (LENZ) stock price?
-
LENZ Therapeutics, Inc.(NASDAQ:LENZ) stock price is $4.81 in the last trading session. During the trading session, LENZ stock reached the peak price of $50.4 while $4.8014 was the lowest point it dropped to. The percentage change in LENZ stock occurred in the recent session was --2.43% while the dollar amount for the price change in LENZ stock was -$-0.12.
-
LENZ's industry and sector of operation?
-
The NASDAQ listed LENZ is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of LENZ?
-
Shawn Olsson | Chief Commercial Officer
Kris Gambelin | Senior Vice President of Regulatory & Clincal Operations
David Choromanski | Vice President of Marketing
Domenick Porfidia | Vice President of Sales
James W. McCollum | Co-Founder & Director -
How many employees does LENZ have?
-
Number of LENZ employees currently stands at 152. LENZ operates from 445 Marine View Avenue, Solana Beach, CA 92014, US.
-
Link for LENZ official website?
-
Official Website of LENZ is: https://www.lenz-tx.com
-
How do I contact LENZ?
-
LENZ could be contacted at phone #(858) 925-7000 and can also be accessed through its website. LENZ operates from 445 Marine View Avenue, Solana Beach, CA 92014, US.
-
How many shares of LENZ are traded daily?
-
The average number of LENZ shares traded daily for last 3 months was 836.63K.
-
What is the market cap of LENZ currently?
-
The market value of LENZ currently stands at $150.81M with its latest stock price at $4.81